Cidara Therapeutics: An Attractive Price For A Niche Opportunity With A High Probability Of Success Seeking Alpha, 05 Dec 2017 Investment Thesis: Cidara Therapeutics is developing a novel echinocandin (CD101) that we believe will compete for first-line…